Drugs / MNK-6105
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04128462 | Nov 2021 → Apr 2025 | hepatic encephalopathy | Mallinckrodt | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNK-6105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04128462 ↗ |
| Route | Intravenous | “continuous intravenous (IV) infusion” NCT04128462 ↗ |